# US 2013/0085469 A1 · Taurolidine formulations and delivery: therapeutic treatments and antimicrobial protection against bacterial biofilm formation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0085469 A1
- Document ID: US20130085469A1
- Status: Published application
- Kind: A1
- Application number: 13/457,091
- Filed: 2012-04-26
- Published: 2013-04-04
- Earliest claimed: 2004-02-03
- Inventors: Hans-Dietrich Polaschegg
- Web page: https://patentgrep.com/patent/US20130085469A1

## CPC

- A61M 1/3687: {Chemical treatment (A61M1/3675 takes precedence)}
- A61K 31/549: having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
- A61L 15/44: Medicaments
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- A61P 1/02: Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A61P 7/08: Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04)
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 13/02: of urine or of the urinary tract, e.g. urine acidifiers
- A61P 15/02: for disorders of the vagina
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 31/04: Antibacterial agents
- A61L 2300/404: Biocides, antimicrobial agents, antiseptic agents
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Treating of localized bacterial infection, comprising locally applying Taurolidine to the infection. A device for insertion into the body, the device comprising Taurolidine to render the device infection resistant. A medication for treating bacterial infections, comprising Taurolidine carried by one of: gels, liquid, thixotropic gels, colloidal mixtures, dispensal suspensions, injectable polymers, or a microparticle. A method for treating blood, comprising: removing blood from the body; treating the blood with Taurolidine; and returning the treated blood.

## Claims

### Claim at position 1

-43. (canceled)

### Claim 44

A method for treating the blood of a patient, the method comprising:
connecting one end of an extracorporeal blood line to the vascular system of the patient, and connecting a second end of the extracorporeal blood line to the vascular system of the patient, so that the blood of the patient will continuously flow through the extracorporeal blood line; and
while the blood is continuously flowing through the extracorporeal blood line, treating the blood with Taurolidine.

### Claim at position 3

-47. (canceled)

### Claim 48 (depends on 44)

The method of claim 44, wherein the Taurolidine is transferred to the blood by dialysis.

### Claim 49 (depends on 44)

The method of claim 44, wherein the Taurolidine is provided in a powder form.

### Claim 50 (depends on 44)

The method of claim 44, wherein the Taurolidine is provided in a granular form.

### Claim 51 (depends on 44)

The method of claim 44, wherein the Taurolidine is provided in a slurry form.

### Claim 52 (depends on 44)

The method of claim 44, wherein the Taurolidine is provided in a liquid form.

### Claim 53 (depends on 48)

The method of claim 48, wherein the Taurolidine is removed from the blood by dialysis.
